본문 바로가기
KERD
논문KCI 등재

MicroRNA Regulation in Systemic Lupus Erythematosus Pathogenesis

Sheng Yan|Lok Yan Yim|Liwei Lu|Chak Sing Lau|Vera Sau-Fong Chan
대한면역학회 (The Korean Association of Immunologists)|2014.06|Immune Network|제14권 제3호|pp. 138-148

3

조회

0

다운로드

2

인용

0

참고문헌

키워드

AutoimmunityMicroRNAsSystemic Lupus Erythematosus

초록

MicroRNAs (miRNAs) are endogenous small RNA molecules best known for their function in post-transcriptional gene regulation. Immunologically, miRNA regulates the differentiation and function of immune cells and its malfunction contributes to the development of various autoimmune diseases including systemic lupus erythematosus (SLE). Over the last decade, accumulating researches provide evidence for the connection between dysregulated miRNA network and autoimmunity. Interruption of miRNA biogenesis machinery contributes to the abnormal T and B cell development and particularly a reduced suppressive function of regulatory T cells, leading to systemic autoimmune diseases. Additionally, multiple factors under autoimmune conditions interfere with miRNA generation via key miRNA processing enzymes, thus further skewing the miRNA expression profile. Indeed, several independent miRNA profiling studies reported significant differences between SLE patients and healthy controls. Despite the lack of a consistent expression pattern on individual dysregulated miRNAs in SLE among these studies, the aberrant expression of distinct groups of miRNAs causes overlapping functional outcomes including perturbed type I interferon signalling cascade, DNA hypomethylation and hyperactivation of T and B cells. The impact of specific miRNA-mediated regulation on function of major immune cells in lupus is also discussed. Although research on the clinical application of miRNAs is still immature, through an integrated approach with advances in next generation sequencing, novel tools in bioinformatics database analysis and new in vitro and in vivo models for functional evaluation, the diagnostic and therapeutic potentials of miRNAs may bring to fruition in the future.

Abstract

MicroRNAs (miRNAs) are endogenous small RNA molecules best known for their function in post-transcriptional gene regulation. Immunologically, miRNA regulates the differentiation and function of immune cells and its malfunction contributes to the development of various autoimmune diseases including systemic lupus erythematosus (SLE). Over the last decade, accumulating researches provide evidence for the connection between dysregulated miRNA network and autoimmunity. Interruption of miRNA biogenesis machinery contributes to the abnormal T and B cell development and particularly a reduced suppressive function of regulatory T cells, leading to systemic autoimmune diseases. Additionally, multiple factors under autoimmune conditions interfere with miRNA generation via key miRNA processing enzymes, thus further skewing the miRNA expression profile. Indeed, several independent miRNA profiling studies reported significant differences between SLE patients and healthy controls. Despite the lack of a consistent expression pattern on individual dysregulated miRNAs in SLE among these studies, the aberrant expression of distinct groups of miRNAs causes overlapping functional outcomes including perturbed type I interferon signalling cascade, DNA hypomethylation and hyperactivation of T and B cells. The impact of specific miRNA-mediated regulation on function of major immune cells in lupus is also discussed. Although research on the clinical application of miRNAs is still immature, through an integrated approach with advances in next generation sequencing, novel tools in bioinformatics database analysis and new in vitro and in vivo models for functional evaluation, the diagnostic and therapeutic potentials of miRNAs may bring to fruition in the future.

참고문헌 (87)

  1. Carthew, R. W., "Origins and Mechanisms of miRNAs and siRNAs", Cell, 136, pp.642~655 (2009)
  2. Kim, V. N., "Biogenesis of small RNAs in animals", Nat. Rev. Mol. Cell Biol, 10, pp.126~139 (2009)
  3. Inui, M., "MicroRNA control of signal transduction", Nat. Rev. Mol. Cell Biol, 11, pp.252~263 (2010)
  4. Bartel, D. P., "MicroRNAs : target recognition and regulatory functions", Cell, 136, pp.215~233 (2009)
  5. Chen, C. Z., "MicroRNAs modulate hematopoietic lineage differentiation", Science, 303, pp.83~86 (2004)
  6. Carrington, J. C., "Role of microRNAs in plant and animal development", Science, 301, pp.336~338 (2003)
  7. Baltimore, D., "MicroRNAs: new regulators of immune cell development and function", Nat. Immunol, 9, pp.839~845 (2008)
  8. O’Connell, R. M, "Physiological and pathological roles for microRNAs in the immune system", Nat. Rev. Immunol, 10, pp.111~122 (2010)
  9. Asirvatham, A. J., "MicroRNA targets in immune genes and the Dicer", Argonaute and ARE machinery components, 2008, pp.45, 1995~2006
  10. Mak, A., "Global trends, potential mechanisms and early detection of organ damage in SLE", Nat. Rev. Rheumatol, 9, pp.301~310 (2013)
  11. Rahman, A., "Systemic lupus erythematosus", N. Engl. J. Med, 358, pp.929~939 (2008)
  12. Tsokos, G. C, "Systemic lupus erythematosus", N. Engl. J. Med, 365, pp.2110~2121 (2011)
  13. Luo, X., "Evidence for microRNA-mediated regulation in rheumatic diseases", Ann. Rheum. Dis, 69(Suppl 1), pp.i30~i36 (2010)
  14. Zhu, S., "MicroRNA in immunity and autoimmunity", J. Mol. Med. (Berl), 91, pp.1039~1050 (2013)
  15. Miao, C. G., "The emerging role of microRNAs in the pathogenesis of systemic lupus erythematosus", Cell. Signal, 25, pp.1828~1836 (2013)
  16. Gregory, R. I., "The Microprocessor complex mediates the genesis of microRNAs", Nature, 432, pp.235~240 (2004)
  17. Lund, E., "Nuclear export of microRNA precursors", Science, 303, pp.95~98 (2004)
  18. Bartel, D. P., "MicroRNAs: genomics, biogenesis, mechanism, and function", Cell, 116, pp.281~297 (2004)
  19. Muljo, S. A, "Aberrant T cell differentiation in the absence of Dicer", J. Exp. Med, 202, pp.261~269 (2005)
  20. Chong, M. M., "The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease", J. Exp. Med, 205, pp.2005~2017 (2008)
  21. Cobb, B. S., "T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer", J. Exp. Med, 201, pp.1367~1373 (2005)
  22. Zhou, X, "Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity", J. Exp. Med, 205, pp.1983~1991 (2008)
  23. Liston, A, "Dicer-dependent microRNA pathway safeguards regulatory T cell function", J. Exp. Med, 205, pp.1993~2004 (2008)
  24. Fontenot, J. D., "Foxp3 programs the development and function of CD4＋ CD25＋ regulatory T cells", Nat. Immunol, 4, pp.330~336 (2003)
  25. Divekar, A. A., "Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu", J. Immunol, 186, pp.924~930 (2011)
  26. Belver, L., "MicroRNAs prevent the generation of autoreactive antibodies", Immunity, 33, pp.713~722 (2010)
  27. Xu, S, "The RNase III enzyme Dicer is essential for germinal center B-cell formation", Blood, 119, pp.767~776 (2012)
  28. Ademokun, A, "Regulation of B-cell differentiation by microRNAs and RNA-binding proteins", Biochem. Soc. Trans, 36, pp.1191~1193 (2008)
  29. Koralov, S. B, "Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage", Cell, 132, pp.860~874 (2008)
  30. Wiesen, J. L, "Dicer is regulated by cellular stresses and interferons", Mol. Immunol, 46, pp.1222~1228 (2009)
  31. Satoh, M., "Autoantibodies to Argonaute 2 (Su antigen)", Adv. Exp. Med. Biol, 768, pp.45~59 (2013)
  32. Jakymiw, A., "Autoimmune targeting of key components of RNA interference", Arthritis Res. Ther, 8, pp.R87~ (2006)
  33. Lu, J., "MicroRNA expression profiles classify human cancers", Nature, 435, pp.834~838 (2005)
  34. Wang, H., "Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus", Transl. Res, 160, pp.198~206 (2012)
  35. Carlsen, A. L, "Circulating microRNA expression profiles associated with systemic lupus erythematosus", Arthritis Rheum, 65, pp.1324~1334 (2013)
  36. Tang, Y., "MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins", Arthritis Rheum, 60, pp.1065~1075 (2009)
  37. Te, J. L, "Identification of unique microRNA signature associated with lupus nephritis", PLoS One, 5, pp.e10344~ (2010)
  38. Baechler, E. C, "Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus", Proc. Natl. Acad. Sci. USA, 100, pp.2610~2615 (2003)
  39. Bennett, L., "Interferon and granulopoiesis signatures in systemic lupus erythematosus blood", J. Exp. Med, 197, pp.711~723 (2003)
  40. Obermoser, G., "The interferon-alpha signature of systemic lupus erythematosus", Lupus, 19, pp.1012~1019 (2010)
  41. Luo, X, "The role of miR-125b in T lymphocytes in the pathogenesis of systemic lupus erythematosus", Clin. Exp. Rheumatol, 31, pp.263~271 (2013)
  42. Lu, M. C, "Decreased microRNA(miR)-145 and increased miR-224 expression in T cells from patients with systemic lupus erythematosus involved in lupus immunopathogenesis", Clin. Exp. Immunol, 171, pp.91~99 (2013)
  43. Zhao, S., "MicroRNA-126 regulates DNA methylation in CD4＋ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1", Arthritis Rheum, 63, pp.1376~1386 (2011)
  44. Stagakis, E, "Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression", Ann. Rheum. Dis, 70, pp.1496~1506 (2011)
  45. Pan, W., "MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4＋ T cells by directly and indirectly targeting DNA methyltransferase 1", J. Immunol, 184, pp.6773~6781 (2010)
  46. Zhu, X., "Analysis of associations between the patterns of global DNA hypomethylation and expression of DNA methyltransferase in patients with systemic lupus erythematosus", Int. J. Dermatol, 50, pp.697~704 (2011)
  47. Richardson, B., "Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis", Arthritis Rheum, 33, pp.1665~1673 (1990)
  48. Zhang, Y., "Impaired DNA methylation and its mechanisms in CD4＋T cells of systemic lupus erythematosus", J. Autoimmun, 41, pp.92~99 (2013)
  49. Qin, H., "MicroRNA-29b contributes to DNA hypomethylation of CD4＋ T cells in systemic lupus erythematosus by indirectly targeting DNA methyltransferase 1", J. Dermatol. Sci, 69, pp.61~67 (2013)
  50. Dai, Y., "Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients", Lupus, 16, pp.939~946 (2007)
  51. Sheedy, F. J., "Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21", Nat. Immunol, 11, pp.141~147 (2010)
  52. Ding, S., "Decreased microRNA-142-3p", 5p expression causes CD4＋ T cell activation and B cell hyperstimulation in systemic lupus erythematosus, 2012, pp.64, 2953~2963
  53. Cannons, J. L, "Optimal germinal center responses require a multistage T cell: B cell adhesion process involving integrins, SLAM-associated protein, and CD84", Immunity, 32, pp.253~265 (2010)
  54. Komori, H, "A signal adaptor SLAM-associated protein regulates spontaneous autoimmunity and Fas-dependent lymphoproliferation in MRL-Faslpr lupus mice", J. Immunol, 176, pp.395~400 (2006)
  55. Alcocer-Varela, J., "Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus", J. Clin. Invest, 69, pp.1388~1392 (1982)
  56. Boyman, O, "The role of interleukin-2 during homeostasis and activation of the immune system", Nat. Rev. Immunol, 12, pp.180~190 (2012)
  57. Fan, W, "Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus", Arthritis Rheum, 64, pp.3715~3725 (2012)
  58. Xue, F., "miR-31 regulates interleukin 2 and kinase suppressor of ras 2 during T cell activation", Genes Immun, 14, pp.127~131 (2013)
  59. Helms, W. S., "Modulation of NFAT-dependent gene expression by the RhoA signaling pathway in T cells", J. Leukoc. Biol, 82, pp.361~369 (2007)
  60. Rouas, R, "Human natural Treg microRNA signature: role of microRNA-31 and microRNA- 21 in FOXP3 expression", Eur. J. Immunol, 39, pp.1608~1618 (2009)
  61. Zhao, X., "MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus", Arthritis Rheum, 62, pp.3425~3435 (2010)
  62. Lu, M. M, "Increased serum RANTES in patients with systemic lupus erythematosus", Rheumatol. Int, 32, pp.1231~1233 (2012)
  63. Song, A., "RFLAT-1: a new zinc finger transcription factor that activates RANTES gene expression in T lymphocytes", Immunity, 10, pp.93~103 (1999)
  64. Liu, Y., "MicroRNA-30a promotes B cell hyperactivity in patients with systemic lupus erythematosus by direct interaction with Lyn", Arthritis Rheum, 65, pp.1603~1611 (2013)
  65. Liossis, S. N, "B-cell kinase lyn deficiency in patients with systemic lupus erythematosus", J. Investig. Med, 49, pp.157~165 (2001)
  66. Flores-Borja, F., "Decreased Lyn expression and translocation to lipid raft signaling domains in B lymphocytes from patients with systemic lupus erythematosus", Arthritis Rheum, 52, pp.3955~3965 (2005)
  67. Zan, H, "Regulation of Aicda expression and AID activity", Autoimmunity, 46, pp.83~101 (2013)
  68. Diaz, M., "The role of activation-induced deaminase in lupus nephritis", Autoimmunity, 46, pp.115~120 (2013)
  69. Jiang, C., "Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL", lpr mice, 2007, pp.178, 7422~7431
  70. Dorsett, Y, "MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation", Immunity, 28, pp.630~638 (2008)
  71. Teng, G, "MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase", Immunity, 28, pp.621~629 (2008)
  72. De Yébenes, V. G, "miR-181b negatively regulates activation-induced cytidine deaminase in B cells", J. Exp. Med, 205, pp.2199~2206 (2008)
  73. Dai, R., "Identification of a common lupus disease-associated microRNA expression pattern in three different murine models of lupus", PLoS One, 5, pp.e14302~ (2010)
  74. Thai, T. H., "Deletion of microRNA- 155 reduces autoantibody responses and alleviates lupus-like disease in the Fas(lpr) mouse", Proc. Natl. Acad. Sci. USA, 110, pp.20194~20199 (2013)
  75. Yuan, Y., "Role of microRNA-15a in autoantibody production in interferon- augmented murine model of lupus", Mol. Immunol, 52, pp.61~70 (2012)
  76. Boldin, M. P., "miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice", J. Exp. Med, 208, pp.1189~1201 (2011)
  77. Hou, J., "MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2", J. Immunol, 183, pp.2150~2158 (2009)
  78. Luo, X., "A functional variant in microRNA- 146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus", PLoS Genet, 7, pp.e1002128~ (2011)
  79. Karrich, J. J., "MicroRNA-146a regulates survival and maturation of human plasmacytoid dendritic cells", Blood, 122, pp.3001~3009 (2013)
  80. Chan, V. S, "Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus", Autoimmun. Rev, 11, pp.890~897 (2012)
  81. Charrier, E., "Post-transcriptional down-regulation of Toll-like receptor signaling pathway in umbilical cord blood plasmacytoid dendritic cells", Cell. Immunol, 276, pp.114~121 (2012)
  82. Jin, O., "Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression", Lupus, 17, pp.654~662 (2008)
  83. Jin, O, "Abnormalities in circulating plasmacytoid dendritic cells in patients with systemic lupus erythematosus", Arthritis Res. Ther, 12, pp.R137~ (2010)
  84. Pan, Y, "MS2 VLP-based delivery of microRNA-146a inhibits autoantibody production in lupus-prone mice", Int. J. Nanomedicine, 7, pp.5957~5967 (2012)
  85. Garchow, B. G., "Silencing of microRNA- 21 in vivo ameliorates autoimmune splenomegaly in lupus mice", EMBO Mol. Med, 3, pp.605~615 (2011)
  86. Keller, A., "Toward the blood-borne miRNome of human diseases. Nat", Methods, 8, pp.841~843 (2011)
  87. Su, X., "miRNomes of haematopoietic stem cells and dendritic cells identify miR-30b as a regulator of Notch1", Nat. Commun, 4, pp.2903~ (2013)

관련 논문AI추천

The Role of MicroRNAs in Regulatory T Cells and in the Immune Response하대유대한면역학회 · Immune Network2011 · 제11권 제1호MicroRNA-mediated Regulation of the Development and Functions of Follicular Helper T cells강승구, 박효성, 엄지영, 이정현대한면역학회 · Immune Network2018 · 제18권 제2호CD72 is a Negative Regulator of B Cell Responses to Nuclear Lupus Self-antigens and Development of Systemic Lupus ErythematosusTakeshi Tsubata대한면역학회 · Immune Network2019 · 제19권 제1호New insights into the role of renal resident cells in the pathogenesis of lupus nephritisGeorge C. Tsokos, Seung-Ki Kwok대한내과학회 · The Korean Journal of Internal Medicine2018 · 제33권 제2호Potential Implications of Long Noncoding RNAs in Autoimmune Diseases허근, 김상현, 김지민대한면역학회 · Immune Network2019 · 제19권 제1호Insights into the Role of Follicular Helper T Cells in Autoimmunity김도현, 김원주, 박홍재, 윤지희, 임상호, 최윤수, 최제민대한면역학회 · Immune Network2014 · 제14권 제1호

이 간행물의 다른 논문 (5건)

Interleukin-32 in Inflammatory Autoimmune Diseases김수현pp. 123-127Differential Roles of Lung Dendritic Cell Subsets Against Respiratory Virus Infection김태훈, 이흥규pp. 128-137Insulin Resistance and Serum Levels of Interleukin-17 and Interleukin-18 in Normal PregnancyAbdolreza Sotoodeh Jahromi, Mohammad Shojaei, Mohamed Amin Ghobadifarpp. 149-155Reduced Interleukin-17 and Transforming Growth Factor Beta Levels in Peripheral Blood as Indicators for Following the Course of Bladder CancerMohamed Amin Ghobadifar, Abbas Ahmadi Vasmehjani1, Ali Dehghani, Rasoul Baharlou, Mahshid Khoubyari, Ali Dehghanipp. 156-163Characterization of Two Novel mAbs Recognizing Different Epitopes on CD43조운동, 김민영, 이재혁, 김승렬, 이용문, 함영준, 홍권표, 홍정원, 문유리, 나형철, 송형근, 윤상순, 김솟을pp. 164-170
원문 보기